These results indicate that HO-1, and specifically HO-1-derived iron, can represent a pathogenic player in cardiomyopathy via iron-dependent ferroptosis and may represent a therapeutic target for inhibition in this context. This evidence concerns the gene HMOX1 and cardiomyopathy.